PDF(Pubmed)
Abstract：
In this editorial, we discuss the article by Agatsuma et al. We concentrate specifically on the current routinely used screening tests recommended by society guidelines and delve into the significance of early diagnosis of colorectal cancer (CRC) and its substantial impact on both incidence and mortality rates. Screening is highly recommended, and an early diagnosis stands out as the most crucial predictor of survival for CRC patients. Therefore, it is essential to identify and address the barriers hindering adherence to screening measures, as these barriers can vary among different populations. Furthermore, we focus on screening strategy optimization by selecting high-risk groups. Patients with comorbidities who regularly visit hospitals have been diagnosed at an early stage, showing no significant difference compared to patients undergoing regular screening. This finding highlights the importance of extending screening measures to include patients with comorbidities who do not routinely visit the hospital.
摘要：
在这篇社论中，我们讨论了Agatsuma等人的文章。我们特别关注社会指南推荐的当前常规使用的筛查测试，并深入研究早期诊断结直肠癌（CRC）的重要性及其对发病率和死亡率的重大影响。强烈建议筛查，早期诊断是CRC患者生存的最关键预测指标。因此,必须确定和解决阻碍坚持筛查措施的障碍，因为这些障碍在不同的人群中可能有所不同。此外，我们通过选择高危人群来优化筛查策略。经常到医院就诊的合并症患者已在早期得到诊断，与接受定期筛查的患者相比，没有显着差异。这一发现强调了扩大筛查措施的重要性，以包括不经常去医院的合并症患者。
